ChemoCentryx Inc (NASDAQ:CCXI)

12.46
Delayed Data
As of 4:00pm ET
 -0.07 / -0.56%
Today’s Change
5.42
Today|||52-Week Range
15.08
+109.41%
Year-to-Date
TherapeuticsMD (TXMD) Soars: Stock Adds 9.1% in Session
Jun 07 / Zacks.com - Paid Partner Content
4 Top-Ranked Nasdaq Stocks That Have Doubled This Year
Jun 05 / Zacks.com - Paid Partner Content
Nektar Therapeutics (NKTR) Jumps: Stock Rises 6.5%
Jun 06 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close12.53
Today’s open12.44
Day’s range12.16 - 12.64
Volume182,707
Average volume (3 months)301,097
Market cap$546.1M
Data as of 4:00pm ET, 06/18/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-363.69%
Earnings growth (next 5 years)--
Revenue growth (last year)+591.22%
P/E ratio43.0
Price/Sales3.58
Price/Book6.84

Competitors

 Today’s
change
Today’s
% change
RARXRa Pharmaceuticals I...+0.10+1.10%
TTPHTetraphase Pharmaceu...-0.07-1.64%
CNCEConcert Pharmaceutic...-0.27-1.37%
AQXPAquinox Pharmaceutic...+0.43+2.81%
Data as of 4:00pm ET, 06/18/2018

Financials

Next reporting dateAugust 7, 2018
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$82.5M
Annual profit (last year)$17.9M
Net profit margin21.65%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Thomas J. Schall
Chief Operating Officer &
Executive Vice President
William Fairey
Corporate headquarters
Mountain View, California

Forecasts